David Krige
Impact in
- Neurology top 2%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Neurological diseases and metabolism
-
- Genetic Neurodegenerative Diseases
Papers in
- Oncology 20
- CAR-T cell therapy research 10
- Peptidase Inhibition and Analysis 7
- Cancer Immunotherapy and Biomarkers 5
-
- Histone Deacetylase Inhibitors Research 5
- Mitochondrial Function and Pathology 5
- Co-authors
- Anthony H.V. Schapira (6 shared papers)Jonathan M. Cooper (6 shared papers)C. D. Marsden (3 shared papers)V. M. Mann (4 shared papers)S. E. Daniel (1 shared paper)Deborah H. Brotherton (1 shared paper)Scott Cuthill (1 shared paper)August Vidal (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Cancer Research (4 papers)Biochimica et Biophysica Acta (BBA) - Bioenergetics (2 papers)Blood (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
David Krige
32 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 77
- Neurology 410
- Cellular and Molecular Neuroscience 313
- Clinical Biochemistry 109
- Neurology 117
- Molecular Biology 657
Countries citing papers authored by David Krige
This map shows the geographic impact of David Krige's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Krige with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Krige more than expected).
Fields of papers citing papers by David Krige
This network shows the impact of papers produced by David Krige. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Krige. The network helps show where David Krige may publish in the future.
Co-authors
The 25 scholars most cited alongside David Krige, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 322 | |
| 2 | 1992 | 306 | |
| 3 | 2011 | 100 | |
| 4 | 1994 | 59 | |
| 5 | 2009 | 45 | |
| 6 | 2021 | 41 | |
| 7 | 2004 | 40 | |
| 8 | 2016 | 39 | |
| 9 | 2023 | 36 | |
| 10 | 2012 | 35 | |
| 11 | 1992 | 33 | |
| 12 | 2015 | 29 | |
| 13 | 2010 | 17 | |
| 14 | 2013 | 11 | |
| 15 | 1992 | 10 | |
| 16 | 2022 | 8 | |
| 17 | 2019 | 7 | |
| 18 | Safety, efficacy and biology of the gp100 TCR-based bispecific T cell redirector IMCgp100 in advanced uveal melanoma | 2017 | 6 |
| 19 | 1997 | 6 | |
| 20 | 2015 | 5 |
About David Krige
David Krige is a scholar working on Oncology, Molecular Biology, Biotechnology, Genetics and Cancer Research, having authored 33 papers that have together received 1.2k indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Cancer Research and Treatments (8 papers), Peptidase Inhibition and Analysis (7 papers), Virus-based gene therapy research (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Histone Deacetylase Inhibitors Research (5 papers), Mitochondrial Function and Pathology (5 papers) and Genetic Neurodegenerative Diseases (4 papers). The work is most often cited by research in Neurology (410 citations), Cellular and Molecular Neuroscience (313 citations), Clinical Biochemistry (109 citations), Neurology (117 citations) and Molecular Biology (657 citations). David Krige has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Anthony H.V. Schapira, Jonathan M. Cooper, C. D. Marsden, V. M. Mann, S. E. Daniel, Deborah H. Brotherton, Scott Cuthill, August Vidal, Shetal Patel and J Owen. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Biochimica et Biophysica Acta (BBA) - Bioenergetics, Blood and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.